Table 4.
Mediation effect of PSV-L_PCL FC on PIGD score via MoCA score
| Effect Type | Path | β | p value | 95% CI |
|---|---|---|---|---|
| Direct effect | PSV-L_PCL FC → PIGD score | −4.90 | 0.049 | (−9.80, −0.01) |
| Indirect effect | PSV-L_PCL FC → MoCA → PIGD score | −2.58 | 0.025 | (−4.84, −0.32) |
| Total effect | PSV-L_PCL FC → PIGD score | −7.48 | 0.004 | (−12.52, −2.45) |
| Path coefficient | MoCA → PIGD score | −0.20 | <0.001 | (−0.31, −0.10) |
| PSV-L_PCL FC → MoCA | 12.62 | 0.005 | (3.78, 21.46) |
The mediation model was adjusted for age, sex, education years, disease duration, LEDD, and UPDRS-III score. Bold indicates statistical significance (p < 0.05). 95% CI based on bootstrapping (5000 samples).
CI confidence interval, LEDD levodopa equivalent daily dose, L_PCL left paracentral lobule, MoCA Montreal Cognitive Assessment, PIGD postural instability and gait difficulty, PSV posterior superior vermis, UPDRS III Unified Parkinson’s Disease Rating Scale Part III.